What's in Weleda AG's pipeline?

Weleda AG has 1 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Weleda AG's portfolio?

Top competitors by shared drug class: Rosenberg European Academy of Ayurveda, Universität Duisburg-Essen.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/weleda-ag.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

Weleda AG — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Weleda AG pipeline: 1 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Bryophyllum p.	Bryophyllum p.	marketed	Herbal/botanical preparation		Dermatology; Wound Care

Therapeutic area mix

Dermatology; Wound Care · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Rosenberg European Academy of Ayurveda · 1 shared drug class
Universität Duisburg-Essen · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Weleda AG:

Cite this brief

Drug Landscape (2026). Weleda AG — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/weleda-ag. Accessed 2026-06-10.